Safety Evaluation of Contezolid (MRX-I) Versus Linezolid in Sprague-Dawley Rats
{{output}}
Background & objectives: Contezolid (MRX-I) is a novel ortho-fluorophenyl dihydropyridone developed by MicuRx Pharmaceuticals, Inc. It has been approved for the treatment of drug-resistant Gram-positive bacterial infections with ... ...
